Copyright
©The Author(s) 2020.
World J Transplant. Mar 31, 2020; 10(3): 64-78
Published online Mar 31, 2020. doi: 10.5500/wjt.v10.i3.64
Published online Mar 31, 2020. doi: 10.5500/wjt.v10.i3.64
Table 1 Cell transplantation
Donor | Recipients (disease, strain etc.) | Outcomes | Year | ||
Cells | Species | Treatments [co-culture (Co), organoid generated] | |||
Hepatocytes | Human | - | Human (ALF) | Hepatic function | 2018[13] |
- | Human (ACLF) | Hepatic function | 2014[22] | ||
- | Human (metabolic disease) | Engraftment, hepatic function | 2012[23] | ||
- | Human (oxalosis) | Hepatic function | 2012[24] | ||
- | Rat (SD) | Hepatic function, survival extension | 2017[25] | ||
- | Mouse (NOD/SCID) | Alb secretion, engraftment | 2017[26] | ||
- | Mouse (FRG) | Engraftment, hepatic function | 2013[27] | ||
- | Mouse (SCID/Alb-uPA) | Analysis of NK cell | 2010[28] | ||
UC-MSC (human) | Mouse (BALB/c) | Engraftment, hepatic function | 2018[29] | ||
Rat | - | Mouse (C57BL/6 FRG) | 2018[30] | ||
- | Rat (Wistar) | Engraftment | 2015[31] | ||
- | Rat (SD) | Engraftment, hepatic function | 2015[32] | ||
- | Rat | Engraftment | 2014[33] | ||
- | Rat (DPP4-) | Engraftment, repopulation | 2014[34] | ||
- | Rat (An alb) | Engraftment, hepatic function | 2014[35] | ||
HSCs (Rat), SECs (Rat)/Co | Mouse (C57BL/6) | Engraftment, survival extension | 2014[36] | ||
- | Rat (SD) | Hepatic function | 2010[37] | ||
Mouse | Organoid | Mouse (C57BL/6) | Engraftment | 2017[38] | |
- | Mouse (emdr2−/−) | Engraftment, Repopulation | 2015[39] | ||
- | Mouse (Fah-/-) | Hepatic function | 2010[40] | ||
- | Mouse (FVB/N) | Engraftment, analysis of metabolite | 2010[41] | ||
- | Mouse (C57BL/6) | Engraftment | 2010[42] | ||
Hepatocytes (fetal) | Rat | - | Rat (DPPIV-) | Engraftment, repopulation | 2018[43] |
Mouse | - | Mouse (C57BL/6) | Engraftment, hepatic function | 2012[44] | |
Liver cells | Rabbit | - | Rabbit (New Zealand) | Hepatic function | 2012[45] |
Hepatic oval cells | Rat | - | Rat (Lewis) | Hepatic function, survival extension | 2013[46] |
Hepatoma cell line | - | Rat (SD) | Hepatic function, survival extension | 2013[47] | |
UC-MSCs | Human | - | Human after OLT | Hepatic function, intervention rate | 2017[48] |
- | Human after OLT | Hepatic function | 2017[49] | ||
BM-MSCs/BM-MNCs | Human | - | Human (LC) | Hepatic function | 2017[50] |
- | 2016[51] | ||||
- | Human (Liver failure) | Hepatic function | 2013[52] | ||
Rabbit | - | Rabbit | Remodeling | 2011[53] | |
BM-MSCs/HSCs | Human | - | Human (EPP) | Engraftment | 2010[54] |
BM-MSC | Human | - | Human (LC) | Engraftment, hepatic function | 2011[55] |
- | Rat (Wistar) | Hepatic function | 2014[56] | ||
- | Mouse (SCID) | Engraftment, analysis of glucose | 2017[57] | ||
- | Mouse (Pfp/Rag2−/−) | Engraftment | 2010[58] | ||
Rhesus macaque | - | Mouse | Hepatic function | 2018[59] | |
Rat | - | Rat (SD) | Hepatic function | 2014[60] | |
BM-MNC-EPC | Rat | - | Rat (SD) | Remodeling | 2012[61] |
Liver-MSCs | Human | - | Mouse (NOD/SCID) | Engraftment, repopulation | 2011[62] |
AD-MSCs | Human | - | Mouse (c57/B6) | Analysis of IRI | 2014[63] |
Mouse | - | Mouse (Swiss CD1) | Repopulation | 2012[64] | |
AD-MSC-Hep | Mouse | - | Mouse (C57BL/6) | Engraftment | 2015[65] |
CD34+ cells | Human | - | Human (LC) | Hepatic function | 2015[66] |
ESCs-Hep | Mouse | - | Mouse (BALB/c) | Engraftment, hepatic function | 2012[67] |
iPSC-Hep | Human | Organoid | Mouse (Alb-Tk-NOG) | Survival extension, hepatic function | 2017[68] |
Organoid | Mouse (NOD/SCID) | Engraftment | 2013[69] | ||
Mouse | - | Mouse (Fah-/- C57Bl/6) | Engraftment | 2010[70] | |
iMPC-Hep | Human | - | Mouse (FRG) | Engraftment | 2014[71] |
GPSCs-Hep | Mouse | - | Mouse (Hfe-null) | Engraftment | 2015[72] |
Liver stem cells | Rat | Organoid | Rat (Fah−/−Il2rg−/−) | Engraftment, hepatic function | 2016[73] |
Table 2 Xeno-organ transplantation
Donor organ | Recipients | Outcomes | Year |
GTKO pig | Tibetan macaques | Cytokine profile | 2017[74] |
Baboon | Survival extension | 2018[5]; 2017[14]; 2014[75]; 2012[76]; 2010[77] | |
Analysis of thrombotic microangiopathy | 2016[78] | ||
Analysis of platelet | 2014[79] | ||
Analysis of rejection | 2012[80] | ||
Platelet aggregation | 2012[81] | ||
Analysis of coagulopathy | 2012 [82] | ||
Hepatic function | 2010[83] | ||
Pig | Baboon | Analysis of immunoglobulin | 2018 [84] |
Rabbit | Porcine, rabbit | Analysis of IgG | 2012[85] |
Table 3 Scaffold-based transplantation
Donor | Recipients (strain) | Outcomes | Year | ||
Scaffold | Species | Seeding cell | |||
Decellularized organ liver | Human | Mouse (C57BL/6J) | Immunogenicity | 2015[2] | |
Porcine | Rat (F344) | Immunogenicity | 2013[86] | ||
Porcine | Immunogenicity | 2013[87] | |||
Porcine | Engraftment | 2012[88] | |||
Sheep, rat | Sheep, rat | Engraftment | 2015[89] | ||
Rat | Hepatocytes (rat), BM- MSCs (Rat) | Rat (Lewis) | Engraftment | 2014[90] | |
Hepatocytes (rat) | Rat (Lewis) | Engraftment, Hepatic function | 2010[91], 2011[92] | ||
Mouse | Hematopoietic progenitor cells (mouse) | Mouse (C57Bl/6) | Hepatic function, metabolic function | 2018 [93] | |
BM-MSCs (mouse) | Mouse (NOD-SCID) | Survival extension, hepatic function | 2014[94] | ||
Placenta | Human | Liver cells (sheep) | Sheep | Survival extension, hepatic function | 2018[15] |
Amniotic membrane | Human | AD-MSCs (human) | Mouse | Survival extension, hepatic function | 2015[95] |
Nonwoven polyglycolic acid scaffolds | Liver cells (human, mouse) | Mouse (NOD/SCID) | Analysis of human metabolite | 2017[19] | |
3D hydrogel | Hepatocytes (human) | Mouse (nude) | Engraftment, hepatic function | 2016[16] | |
Hyaluronan tube | Hepatocytes (rat), adipose-MSCs (human) | Rat (nude) | Engraftment, hepatic function | 2016[17] | |
Polyethylene glycol hydrogels | Hepatocytes (rat) | Mouse (Nude) | Engraftment | 2015[20] | |
Microbeads | Hepatocytes (rat) | Rat (SD) | Hepatic function | 2014 [96] | |
Poly-L-glycolic acid | Hepatocytes (mouse) | Mouse (NOD/SCID) | Engraftment | 2014[21] | |
Hyaluronan hydrogels | Hepatic stem cells (human) | Mouse (Athymic nude) | Engraftment | 2013[97] | |
Apatite-fiber scaffold | Hepatocytes (mouse) + HSC + SECs | Mouse (BALB/CA nu) | Hepatic function | 2011[98] | |
Chitosan-alginate fibrous scaffolds | BM-MSCs (human) | Rat (Wistar) | Hepatic function | 2010[99] | |
Hyaluronic acid sponge | Fetal hepatocyte (rat) | Rat (LEC) | Engraftment, hepatic function | 2010[18] |
Table 4 Sources of alternative therapy
Donors | Species | Numbers |
Organ liver | Total | 25 |
Human | 1[2] | |
Porcine | 16[5,14,74-84,86-88] | |
Sheep | 1[89] | |
Rabbit | 1[85] | |
Rat | 4[89-92] | |
Mouse | 2[93,94] | |
Hepatocytes (adult) | Total | 31 |
Human | 10[13,16,22-29] | |
Rat | 14[17,20,30-37,90-92,96] | |
Mouse | 7[21,38-42,98] | |
Hepatocytes (fetal) | Total | 3 |
Rat | 2[18,43] | |
Mouse | 1[44] | |
Liver cells | Total | 3 |
Human | 1[19] | |
Sheep | 1[15] | |
Rabbit | 1[45] | |
MSCs (umbilical cord) | Human | 3[29,48,49] |
MSCs (bone marrow) | Total | 15 |
Human | 9[50-52,54-58,99] | |
Macaques | 1[59] | |
Rabbit | 1[53] | |
Rat | 3[60,61,90] | |
Mouse | 1[94] | |
MSCs (Adipose) | Total | 4 |
Human | 2[17,63] | |
Mouse | 2[64,65] | |
MSCs (liver) | Human | 1[62] |
Hematopoietic stem cells | Human | 2[54,66] |
ESCs | Mouse | 1[67] |
iPSCs | Total | 3 |
Human | 2[68,69] | |
Mouse | 1[70] | |
GPSCs | Mouse | 1[72] |
Liver stem cells | Total | 2 |
Human | 1[97] | |
Rat | 1[73] |
- Citation: Furuta T, Furuya K, Zheng YW, Oda T. Novel alternative transplantation therapy for orthotopic liver transplantation in liver failure: A systematic review. World J Transplant 2020; 10(3): 64-78
- URL: https://www.wjgnet.com/2220-3230/full/v10/i3/64.htm
- DOI: https://dx.doi.org/10.5500/wjt.v10.i3.64